Requirements for laboratory testing for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (Fifth Edition, 2025)
From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) assumed responsibility for coordinating the National Pathology Accreditation (NPA) Scheme and supporting the development of the Pathology Standards.
Requirements for laboratory testing for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (Fifth Edition, 2025) in currently in use.
This Standard sets out the requirements for pathology practice related to HIV and HCV to ensure it is safe and of high-quality. The 2026 amendment supports:
- a consistent national approach to automatic reflexive HCV RNA testing
- the goal of eliminating HCV as a public health threat by 2030
- harmonisation of testing algorithms with international practice
| The Commission is undergoing a review process for each of the Pathology Standards. To stay informed about upcoming consultations and provide input, please sign up for ongoing updates. You can also read the latest in pathology news. |
For more information about the NPA scheme please visit National Pathology Accreditation Scheme or email the Pathology Standards team.
Downloads
Requirements for laboratory testing for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (Fifth Edition, 2025)
- For more information:
- National Pathology Accreditation Scheme
- Publication Year:
- 2025
- Resource Type:
- Standard
Accessibility: We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright: Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.